SOPHiA GENETICS S.A.
Market Cap
$358.34M
P/E Ratio
-4.27
EPS
$-1.17
Dividend Yield
0.00%
52-Week Range
$2.58 — $5.70
Volume
133.42K
Avg Volume
192.48K
Beta
1.14
P/E (TTM)
-4.27
Forward P/E
—
PEG Ratio
0.89
P/S (TTM)
4.28
P/B (TTM)
6.67
P/FCF
—
EV/EBITDA
—
EV/Sales
—
ROE (TTM)
-1.17%
ROA (TTM)
-0.48%
ROIC
—
Gross Margin
0.67%
Operating Margin
-0.91%
Net Margin
—
Debt/Equity
1.34
Current Ratio
1.96
EPS Growth (YoY)
—
Revenue Growth (YoY)
—
EPS Growth (3Y)
+0.10%
EPS Growth (5Y)
-0.17%
Sales Growth (3Y)
+0.18%
Sales Growth (5Y)
+0.22%
EPS Est (This Year)
$-0.90
EPS Est (Next Year)
$-0.73
Dividend Yield
—
Annual Dividend
—
Payout Ratio
—
Frequency
—
Ex-Dividend Date
—
Cash/Share
$1.03
Institutional %
—
Inst. Net Change
—
Insider Net Shares (90d)
—
Outstanding Shares
67.85M
Float
50.98M
Free Float %
75.14%
Sector
Healthcare
Industry
Medical - Healthcare Information Services
Country
CH
Exchange
NASDAQ
IPO Date
2021-07-23
Employees
423
CEO
Jurgi Camblong
Index Membership
—
Website
https://www.sophiagenetics.com
SOPHiA GENETICS S.A. (SOPH) is a healthcare company in the medical - healthcare information services industry listed on the NASDAQ. With a market capitalization of $358.34M, a P/E ratio of -4.27, SOPH is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare SOPH against other stocks using dozens of fundamental and technical filters.
SOPHiA GENETICS S.A. (SOPH) has a trailing twelve-month (TTM) P/E ratio of -4.27. This is below the market average, which may suggest the stock is undervalued or has lower growth expectations. The P/E ratio measures how much investors are willing to pay per dollar of earnings.
No, SOPHiA GENETICS S.A. (SOPH) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.
SOPHiA GENETICS S.A. (SOPH) has a market capitalization of $358.34 million, classifying it as a small-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.